相似文献
1
The DOPPS practice monitor for US dialysis care: potential impact of recent guidelines and regulatory changes on management of mineral and bone disorder among US hemodialysis patients.
Am J Kidney Dis. 2014 May;63(5):851-4. doi: 10.1053/j.ajkd.2014.02.003. Epub 2014 Mar 5.
2
Commentary on 'the DOPPS practice monitor for US dialysis care: potential impact of recent guidelines and regulatory changes on management of mineral and bone disorder among US hemodialysis patients': the calm before the 2016 storm?
Am J Kidney Dis. 2014 May;63(5):854-8. doi: 10.1053/j.ajkd.2014.03.002.
3
The DOPPS Practice Monitor for US Dialysis Care: PTH Levels and Management of Mineral and Bone Disorder in US Hemodialysis Patients.
Am J Kidney Dis. 2015 Sep;66(3):536-9. doi: 10.1053/j.ajkd.2015.07.011.
4
KDOQI US commentary on the 2009 KDIGO Clinical Practice Guideline for the Diagnosis, Evaluation, and Treatment of CKD-Mineral and Bone Disorder (CKD-MBD).
Am J Kidney Dis. 2010 May;55(5):773-99. doi: 10.1053/j.ajkd.2010.02.340. Epub 2010 Apr 3.
5
How to apply and adapt international guidelines on bone metabolism and disease to the management of Japanese dialysis patients.
Ther Apher Dial. 2005 Feb;9(1):1-2. doi: 10.1111/j.1774-9987.2005.00204.x.
6
Clinical practice guideline for the management of chronic kidney disease-mineral and bone disorder.
Ther Apher Dial. 2013 Jun;17(3):247-88. doi: 10.1111/1744-9987.12058.
7
Hemodialysis Facility Variation in Hospitalization and Transfusions Using Medicare Claims: The DOPPS Practice Monitor for US Dialysis Care.
Am J Kidney Dis. 2016 Feb;67(2):337-40. doi: 10.1053/j.ajkd.2015.10.002. Epub 2015 Oct 31.
8
The economic impact of improving phosphate binder therapy adherence and attainment of guideline phosphorus goals in hemodialysis patients: a Medicare cost-offset model.
Adv Ther. 2014 Dec;31(12):1272-86. doi: 10.1007/s12325-014-0170-4. Epub 2014 Dec 6.
9
Financial implications of choice of dialysis type of the revised Medicare payment system: an economic analysis.
Am J Kidney Dis. 2012 Aug;60(2):280-7. doi: 10.1053/j.ajkd.2012.03.010. Epub 2012 May 5.
10
Is it time for Medicare to provide reimbursement for daily hemodialysis?
Nephrol News Issues. 2001 Apr;15(5):57-9.
引用本文的文献
1
Payment systems for dialysis and their effects: a scoping review.
BMC Health Serv Res. 2023 Jan 17;23(1):45. doi: 10.1186/s12913-022-08974-4.
2
Adherence to the Kidney Disease: Improving Global Outcomes CKD Guideline in Nephrology Practice Across Countries.
Kidney Int Rep. 2020 Dec 17;6(2):437-448. doi: 10.1016/j.ekir.2020.11.039. eCollection 2021 Feb.
3
International and Racial Differences in Mineral and Bone Disorder Markers and Treatments Over the First 5 Years of Hemodialysis in the Dialysis Outcomes and Practice Patterns Study.
Kidney Med. 2019 May 10;1(3):86-96. doi: 10.1016/j.xkme.2019.04.004. eCollection 2019 May-Jun.
4
Bundled Payment Reform and Dialysis Facility Closures in ESKD.
J Am Soc Nephrol. 2020 Mar;31(3):579-590. doi: 10.1681/ASN.2019060575. Epub 2020 Feb 4.
5
A New Data Analysis System to Quantify Associations between Biochemical Parameters of Chronic Kidney Disease-Mineral Bone Disease.
PLoS One. 2016 Jan 25;11(1):e0146801. doi: 10.1371/journal.pone.0146801. eCollection 2016.
6
The Peritoneal Dialysis Outcomes and Practice Patterns Study (PDOPPS): Unifying Efforts to Inform Practice and Improve Global Outcomes in Peritoneal Dialysis.
Perit Dial Int. 2016 May-Jun;36(3):297-307. doi: 10.3747/pdi.2014.00288. Epub 2015 Nov 2.
7
The DOPPS Practice Monitor for US Dialysis Care: PTH Levels and Management of Mineral and Bone Disorder in US Hemodialysis Patients.
Am J Kidney Dis. 2015 Sep;66(3):536-9. doi: 10.1053/j.ajkd.2015.07.011.
8
Gaps between Global Guidelines and Local Practices in CKD-MBD.
Electrolyte Blood Press. 2014 Dec;12(2):35-40. doi: 10.5049/EBP.2014.12.2.35. Epub 2014 Dec 31.
9
Performance measures in dialysis facilities: what is the goal?
Clin J Am Soc Nephrol. 2015 Jan 7;10(1):156-8. doi: 10.2215/CJN.04780514. Epub 2014 Sep 4.
本文引用的文献
1
Medicare program; end-stage renal disease prospective payment system. Final rule.
Fed Regist. 2010 Aug 12;75(155):49029-214.
2
KDOQI US commentary on the 2009 KDIGO Clinical Practice Guideline for the Diagnosis, Evaluation, and Treatment of CKD-Mineral and Bone Disorder (CKD-MBD).
Am J Kidney Dis. 2010 May;55(5):773-99. doi: 10.1053/j.ajkd.2010.02.340. Epub 2010 Apr 3.
3
KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD).
Kidney Int Suppl. 2009 Aug(113):S1-130. doi: 10.1038/ki.2009.188.
4
K/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease.
Am J Kidney Dis. 2003 Oct;42(4 Suppl 3):S1-201.
5
Coronary-artery calcification in young adults with end-stage renal disease who are undergoing dialysis.
N Engl J Med. 2000 May 18;342(20):1478-83. doi: 10.1056/NEJM200005183422003.
Zotero 插件